The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Medical oncology (Northwood, London, England)

Volumn 26 Suppl 1, Issue , 2009, Pages 3-12

  Romo de Vivar Chavez, Antonio ^a   de Vera, Michael E ^a   Liang, Xiaoyan ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 2;

HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; KIDNEY CARCINOMA; KIDNEY TUMOR; METASTASIS; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KIDNEY NEOPLASMS;

EID: 64549130445     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9162-z     Document Type: Review

References (70)